Therapeutic potential of pyruvate therapy for mitochondrial diseases

被引:49
作者
Tanaka, Masashi [1 ]
Nishigaki, Yutaka [1 ]
Fuku, Noriyuki [1 ]
Ibi, Tohru [2 ]
Sahashi, Ko [3 ]
Koga, Yasutoshi [4 ]
机构
[1] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Tokyo 1730015, Japan
[2] Aichi Med Univ, Coll Nursing, Aichi 4801195, Japan
[3] Aichi Med Univ, Dept Neurol, Aichi 4801195, Japan
[4] Kurume Univ, Sch Med, Dept Pediat, Kurume, Fukuoka 830, Japan
关键词
D O I
10.1016/j.mito.2007.07.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:399 / 401
页数:3
相关论文
共 14 条
[11]   Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency [J].
Saheki, T ;
Kobayashi, K ;
Iijima, M ;
Nishi, I ;
Yasuda, T ;
Yamaguchi, N ;
Gao, HZ ;
Jalil, MA ;
Begum, L ;
Li, MX .
METABOLIC BRAIN DISEASE, 2002, 17 (04) :335-346
[12]   Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD) [J].
Saheki, T ;
Kobayashi, K .
JOURNAL OF HUMAN GENETICS, 2002, 47 (07) :333-341
[13]  
VOET D, 1995, BIOCHEMISTRY-US, P485
[14]  
VOET D, 1995, SOLUTIONS MANUAL ACC, P113